ArticleJournal of pharmacy & bioallied sciences2025
A Cross-Sectional Study of Depression in Rheumatoid Arthritis Patients at a Tertiary Care Center.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Depression and Quality of Life in Patients with Rheumatoid Arthritis: The Impact of Self-Disgust.Journal of multidisciplinary healthcare · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rheumatoid arthritis (RA) is a chronic autoimmune condition often linked with depression, worsening symptoms, and lowering the quality of life. This study evaluated the prevalence of depression in female RA patients and its relationship with RA activity and inflammatory markers. Material and Methods: A cross-sectional study was conducted over 18 months, involving 185 female RA patients with depression, diagnosed using DSM-5 criteria. RA disease activity was assessed using the Disease Activity Score 28 (DAS 28), and inflammatory markers, including CRP, ESR, RF, and anti-CCP, were evaluated. Data analysis was performed using SPSS version 20.0. Results: Depression was present in 72.4% of patients, with mild, moderate, and severe depression observed in 31.4%, 26.5%, and 14.6%, respectively. Significant associations were found between depression severity and RA activity ( Conclusion: High depression prevalence in RA patients, especially those with severe disease activity, highlights the need for integrated mental health and RA care to enhance patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.